🇺🇸 FDA
Pipeline program

anti-thymocyte globulin

CDR0000570260

Unknown mab active

Quick answer

anti-thymocyte globulin for Leukemia is a Unknown program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Leukemia
Phase
Unknown
Modality
mab
Status
active

Clinical trials